A range of new studies suggest that a COVID-19 booster shot may provide protection against future variants for many months, even years, The New York Times reports. A recent study posted on bioRxiv, for instance, suggests that a third Pfizer-BioNTech or Moderna shot helps to produce antibodies that could be effective against yet-unseen mutations — even though the vaccines were "not specifically designed to protect against variants." "If people are exposed to another variant like Omicron, they now got some extra ammunition to fight it," Dr. Julie McElrath, a Seattle infectious disease physician, told the Times.
The new findings are similar to those found in the wake of the SARS epidemic that swept across Asia in 2003; one study found that people exposed to SARS at the time were still producing T cells — specialized immune cells — 17 years later. "Memory responses can last for ages," Wendy Burgers, an immunologist at the University of Cape Town, also told the Times. "Potentially, the T-cell response is extremely long-lived."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
